Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
This study has been completed.
Sponsor:
Mitsubishi Tanabe Pharma Corporation
Information provided by:
Mitsubishi Tanabe Pharma Corporation
ClinicalTrials.gov Identifier:
NCT00862992
First received: March 15, 2009
Last updated: September 8, 2009
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2009 |
| Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |